FDA clearance 510(k)
The new clearance expands its insulin dosing support to bolus and premixed insulin titration for Type 2 diabetes.
RapidAI, a health tech company specializing in stroke imaging, has received clearance from the FDA for its Rapid ASPECTS neuroimaging analysis device.
The AI tool can now be used to triage radiology scans with intracranial bleeds, mass effect, midline shift, and cranial fractures.